Find Investable Startups and Competitors
Search thousands of startups using natural language—just describe what you're looking for
Top 50 Clinical Trial Platform in LATAM
Discover the top 50 Clinical Trial Platform startups in LATAM. Browse funding data, key metrics, and company insights. Average funding: $27.7M.
Sort by
The startup is developing a Clinical Digital Twin Platform that creates virtual replicas of patients using real-time health data and advanced modeling techniques. This platform enables healthcare providers to personalize treatment plans and improve patient outcomes by simulating various clinical scenarios.
Funding: $107.1M
Rough estimate of the amount of funding raised
Funding: $107.1M
Rough estimate of the amount of funding raised
Onc.ai develops AI models leveraging oncology real-world data, including imaging, EMR, and genomics, to enhance precision oncology. The company's deep learning imaging AI aims to bring clarity to cancer treatment decision-making for medical oncologists. Initial products focus on predicting clinical outcomes in metastatic lung cancer to support pharmaceutical clinical development.
Funding: $31.0M
Rough estimate of the amount of funding raised
National Cancer Institute
National Cancer Institute
Funding: $31.0M
Rough estimate of the amount of funding raised
Sofya is a clinical reasoning platform that utilizes explainable AI to automate routine tasks and support complex clinical decision-making, integrating seamlessly with electronic health records. By enhancing efficiency and personalization in patient care, Sofya addresses the overwhelming administrative burden on healthcare professionals, reducing the time spent on digital paperwork and minimizing medical errors.
resistanceBio develops oncology drugs that focus on understanding and preventing drug resistance by mimicking the long-term evolution of cancer in a controlled environment. Their platform enables the identification of resistance pathways and the development of longer-lasting therapies, addressing the critical issue of treatment-resistant cancer that contributes to 90% of cancer mortality.
5+
1K+Approximate amount of employees
Funding: $12.8M
Rough estimate of the amount of funding raised
Funding: $12.8M
Rough estimate of the amount of funding raised
The startup develops an AI-driven health tech software that enhances patient-clinic interactions through personalized and secure communication. This solution improves patient engagement and adherence to treatment, leading to better health outcomes in healthcare settings.
Funding: $350.0K
Rough estimate of the amount of funding raised
ABSeed Ventures
ABSeed Ventures
Funding: $350.0K
Rough estimate of the amount of funding raised
Glycomine is developing GLM101, a mannose-1-phosphate replacement therapy currently in clinical trials for PMM2-CDG, a rare genetic disease caused by glycosylation defects. This therapy aims to restore the missing biochemical function, offering potential disease modification rather than merely symptomatic relief.
20+
2K+Approximate amount of employees
Funding: $35.0M
Rough estimate of the amount of funding raised
AbingworthSanofi Ventures
AbingworthSanofi Ventures
Funding: $35.0M
Rough estimate of the amount of funding raised
Asistx is a real-time telemedicine platform that integrates remote patient monitoring (RPM) and artificial intelligence to enhance patient diagnosis and ongoing health management. The platform addresses the inefficiencies in traditional healthcare by enabling continuous monitoring and proactive intervention for chronic and acute conditions, significantly reducing response times and improving patient outcomes.
Founded 2024
Embryoxite develops an AI-powered platform that analyzes embryo metabolomic data, genetic profiles, and morphokinetic imaging to assess implantation potential in pre-implantation embryos. This technology addresses the high failure rate of embryo implantation in IVF procedures by providing objective, data-driven insights that enhance selection accuracy and improve pregnancy outcomes.
MassChallenge Switzerland
The startup develops a generative artificial intelligence infrastructure that utilizes agent-based model-agnostic technology for evaluating and monitoring healthcare applications. Its software enables healthcare institutions to enhance operational efficiency and improve clinical outcomes by providing proprietary evaluation techniques and end-to-end lifecycle management.
25+
1K+Approximate amount of employees
Funding: $30.0M
Rough estimate of the amount of funding raised
Frist Cressey VenturesHealthier Capital
Frist Cressey VenturesHealthier Capital
Funding: $30.0M
Rough estimate of the amount of funding raised
Siolta Therapeutics develops targeted live biotherapeutics using its Precision Symbiotics Platform™ to create therapeutic microbial consortia that address inflammatory diseases. The company combines clinical data and microbial science to target disease-specific mechanisms, aiming to meet the high unmet medical needs in this area.
Funding: $47.1M
Rough estimate of the amount of funding raised
Khosla VenturesSymBiosis
Khosla VenturesSymBiosis
Funding: $47.1M
Rough estimate of the amount of funding raised
Clear Labs is a biotechnology firm that utilizes a genomics system to enhance diagnostic accuracy in clinical and application sectors. The company addresses the complexity of traditional diagnostic processes by providing streamlined genomic analysis, enabling faster and more reliable results.
Funding: $156.5M
Rough estimate of the amount of funding raised
Alumni VenturesKhosla VenturesMenlo Ventures
Alumni VenturesKhosla VenturesMenlo Ventures
Funding: $156.5M
Rough estimate of the amount of funding raised
Neomed offers a digital platform focused on cardiovascular health, providing solutions for disease prevention, management, and remote diagnostics. Their integrated tools support the full patient journey, from early detection to emergency care, for clinics, hospitals, and healthcare providers. Neomed aims to improve cardiac health outcomes through technology-driven solutions.
Nilo provides a SaaS platform utilizing Artificial Intelligence and automation to enhance the financial results and operational efficiency of healthcare institutions. The solution supports ecosystems, providers, and payers by creating digital patient journeys that improve acquisition, conversion, and retention. Key features include AI agents for risk stratification and care navigation, integrated data management via HL7 FHIR, and performance dashboards for clinical and operational oversight.
Funding: $13.1M
Rough estimate of the amount of funding raised
Global Founders CapitalUpload Ventures
Global Founders CapitalUpload Ventures
Funding: $13.1M
Rough estimate of the amount of funding raised
Zeto offers a wireless, dry electrode EEG headset designed for hospital use, eliminating the need for gel application and extensive preparation. This technology enables rapid and efficient brain activity monitoring, improving patient comfort and streamlining clinical workflows.
Funding: $31.0M
Rough estimate of the amount of funding raised
Mindworks Global
Mindworks Global
Funding: $31.0M
Rough estimate of the amount of funding raised
Trak is a tele-rehabilitation platform that utilizes AI to provide personalized exercise plans and monitor patient progress in real-time, enhancing adherence to treatment protocols. By enabling healthcare professionals to conduct remote physiotherapy sessions, Trak reduces rehabilitation time and costs while improving patient outcomes.
Funding: $2.3M
Rough estimate of the amount of funding raised
Decelera
Decelera
Funding: $2.3M
Rough estimate of the amount of funding raised
Neomed is a marketplace that facilitates the secure exchange of medical records among hospitals, laboratories, and physicians, enhancing interoperability and data accessibility. This platform addresses the inefficiencies and communication barriers in healthcare data management, improving patient care coordination and operational workflows.
Axenya provides an integrated corporate health platform combining brokerage, benefits administration, and consulting services with digital operations. The platform leverages advanced analytics and AI for claims management, predictive modeling, and financial reconciliation of health plans. It focuses on proactive clinical navigation and wellness integration to optimize health outcomes and deliver measurable financial ROI for employers.
Funding: $6.0M
Rough estimate of the amount of funding raised
Zentynel Frontier Investments
Zentynel Frontier Investments
Funding: $6.0M
Rough estimate of the amount of funding raised
The startup develops inhaled therapeutics that restore ion balance in the lungs of cystic fibrosis patients, improving lung function and overall health-related quality of life. Their approach also has potential applications in treating fungal infections, providing a new therapeutic avenue for affected individuals.
Prosit is a digital health platform that enables healthcare professionals to manage patient appointments, electronic medical records, and treatment tracking in one integrated system. This solution addresses the challenges of patient communication and care continuity, enhancing the efficiency and quality of healthcare delivery.
Fullscript is a digital health platform that enables healthcare providers to create personalized supplement plans and order lab tests, enhancing patient engagement and adherence through automated reminders and progress tracking. By integrating with over 30 EHR systems, Fullscript streamlines the workflow for practitioners, allowing them to offer affordable, evidence-based health solutions while maintaining control over patient costs.
Funding: $240.0M
Rough estimate of the amount of funding raised
HGGCSnapdragon Capital Partners
HGGCSnapdragon Capital Partners
Funding: $240.0M
Rough estimate of the amount of funding raised
Rapha provides an open health platform focused on improving access to and management of healthcare. By placing the patient at the center of decision-making, Rapha promotes connected and humanized care.
The startup develops personalized pharmaceutical technology that tailors medication regimens based on individual patient profiles, enhancing therapeutic efficacy and minimizing adverse effects. By utilizing advanced data analytics and pharmacogenomics, the company aims to improve patient outcomes and overall quality of life.
Funding: $250.0K
Rough estimate of the amount of funding raised
SF500
SF500
Funding: $250.0K
Rough estimate of the amount of funding raised
The startup offers an online healthcare platform that enables healthcare providers to issue digital medical prescriptions and facilitates the online ordering of medications from local pharmacies. This service allows patients to receive their prescriptions and medications at home, eliminating the need for in-person visits to pharmacies.
Funding: $60.5M
Rough estimate of the amount of funding raised
Matrix Partners
Matrix Partners
Funding: $60.5M
Rough estimate of the amount of funding raised
Cannect is a digital platform that connects researchers, healthcare institutions, and patients to facilitate access to medical cannabis treatments. By providing a streamlined process for consultations, prescriptions, and product procurement, Cannect addresses the challenges of navigating medical cannabis care in Brazil.
Funding: $8.2M
Rough estimate of the amount of funding raised
Supera Capital
Supera Capital
Funding: $8.2M
Rough estimate of the amount of funding raised
WebMed offers a cloud-based management platform that connects patients with healthcare providers through a customized questionnaire, streamlining access to diagnostics and treatment. The platform integrates healthcare data to enhance patient journeys, improve operational efficiency, and ultimately save lives.
Founded 2017
This platform integrates disparate health data from wearables, symptoms, and lifestyle inputs to create a comprehensive user health profile. It utilizes this integrated data to provide science-based, personalized recommendations for nutrition, activity, and recovery that adapt in real-time. The service also generates professional health summaries designed to facilitate clearer communication between users and their healthcare providers.
Single Helix Genomics has developed an automated, portable device that delivers therapeutics on demand, utilizing advanced genomic technologies for precise treatment applications. This device addresses the need for immediate and personalized therapeutic solutions in various medical settings, enhancing patient care and treatment efficiency.
Founded 2020
Univa is developing digital tools that utilize data analytics and machine learning to enhance the management, monitoring, and treatment of eating disorders, addressing the critical shortage of accessible and effective care. By collaborating with healthcare teams, Univa aims to improve patient outcomes and reduce the high morbidity and mortality rates associated with these conditions.
Funding: $1.3M
Rough estimate of the amount of funding raised
YZR Capital
YZR Capital
Funding: $1.3M
Rough estimate of the amount of funding raised
Choiz provides a personalized healthcare platform that integrates diagnostic services, medication delivery, and ongoing patient care management. This approach addresses the fragmentation in healthcare by streamlining the patient journey, improving access to necessary treatments and support.
Funding: $1.5M
Rough estimate of the amount of funding raised
Insud Pharma
Insud Pharma
Funding: $1.5M
Rough estimate of the amount of funding raised
Nuwacell specializes in the research, development, and production of induced pluripotent stem cell (iPSC)-derived therapies for clinical applications. The company addresses the need for effective cell-based treatments in regenerative medicine by providing scalable and reliable cell therapy products.
Founded 2016
PEOPL is a digital health platform that utilizes mobile technology and data analytics to enhance medication adherence among chronic disease patients globally. The platform addresses the challenge of non-compliance by providing personalized reminders and tracking tools to improve patient outcomes and reduce healthcare costs.
Founded 2022
Pixeon provides healthcare management software, including Electronic Health Records (EHR), Radiology Information Systems (RIS), and Laboratory Information Systems (LIS), to enhance operational efficiency in hospitals, clinics, and laboratories. The platform addresses inefficiencies in patient data management and diagnostic processes, enabling real-time monitoring and streamlined workflows across healthcare institutions in Brazil and Latin America.
250+
50K+Approximate amount of employees
Munai provides an AI-driven clinical intelligence platform that integrates with electronic health records to analyze patient data in real-time. The system automates protocols, generates predictive risk alerts, and offers a 360-degree patient view to support multidisciplinary teams. This capability helps hospitals anticipate clinical deterioration, optimize treatment duration, and improve overall operational efficiency.
Funding: $2.3M
Rough estimate of the amount of funding raised
Funding: $2.3M
Rough estimate of the amount of funding raised
VivaWell provides a digital health and wellness platform that uses AI and data science to deliver personalized health programs and quality healthcare. It helps individuals and organizations improve health outcomes and manage healthcare costs through tailored services and population health insights.
Funding: $1.6M
Rough estimate of the amount of funding raised
Funding: $1.6M
Rough estimate of the amount of funding raised
DoctorAssistant.ai provides an AI-powered platform that records medical consultations in real time, transcribes the dialogue, and generates structured clinical notes with suggested ICD codes and parsed exam results. The web‑based solution offers customizable SOAP or specialty templates, secure end‑to‑end encryption, and integration with major EHR systems to streamline documentation for physicians and healthcare facilities.
Rosebud Biosciences develops targeted therapies for rare pediatric genetic diseases using patient-specific organoid models. The company engineers micropatterned 2.5D organoids from induced pluripotent stem cells that replicate individual genetic mutations for drug screening. This platform enables the high-throughput testing of small molecules, gene therapies, and RNA therapeutics against complex developmental disorders.
Y Combinator
Precision Data provides a business intelligence platform that utilizes generative artificial intelligence to optimize access to over 8 billion lines of structured clinical data, enhancing real-world evidence studies in healthcare. The company addresses the challenge of data quality and accessibility, enabling healthcare organizations to make informed decisions based on accurate and comprehensive information.
Huna develops an AI engine that analyzes routine blood test data to identify risk patterns for early cancer detection and other chronic diseases. This technology enables healthcare providers to classify patients by risk level, improving clinical decision-making and increasing the chances of successful treatment while reducing overall healthcare costs.
Funding: $850.0K
Rough estimate of the amount of funding raised
Funding: $850.0K
Rough estimate of the amount of funding raised
Medictalks develops healthcare community software that facilitates knowledge sharing among medical professionals through webinars, articles, and video content. The platform addresses the need for accessible, high-quality medical education and collaboration across various specialties, enhancing professional development and engagement in the healthcare sector.
Funding: $12.0M
Rough estimate of the amount of funding raised
Funding: $12.0M
Rough estimate of the amount of funding raised
Comsentimento develops an AI-driven platform for clinical data transformation and research, focusing on enhancing cancer treatment and facilitating access to clinical trials. The platform provides healthcare professionals with actionable insights and support for chronic disease management, improving patient care and treatment adherence.
Funding: $390.0K
Rough estimate of the amount of funding raised
Incubate Fund
Incubate Fund
Funding: $390.0K
Rough estimate of the amount of funding raised
SigmaMD is a health management platform that integrates AI-powered electronic health records (EHR), patient communication tools, and billing systems to streamline practice operations for direct care providers. This solution addresses inefficiencies in patient management and administrative tasks, allowing clinicians to focus on delivering high-quality patient care.
Voa Health is an AI-driven application that transcribes and processes medical consultations in real-time, generating clinical documentation such as anamneses and prescriptions without the need for manual input. This technology reduces the time clinicians spend on administrative tasks, allowing for more direct patient interaction and improved care quality.
Funding: $250.0K
Rough estimate of the amount of funding raised
Funding: $250.0K
Rough estimate of the amount of funding raised
Arkangel AI is a no-code platform that transforms medical data into AI algorithms for early disease detection, enabling healthcare organizations to build and deploy tailored solutions efficiently. By streamlining processes such as patient triage and drug adverse effect prediction, Arkangel AI enhances healthcare outcomes while significantly reducing operational costs.
Funding: $150.0K
Rough estimate of the amount of funding raised
Funding: $150.0K
Rough estimate of the amount of funding raised
The startup has developed a clinical research platform that utilizes machine learning to target the biological processes of aging, facilitating the discovery of therapies for age-related diseases such as cardiovascular and neurodegenerative conditions. By enabling pharmaceutical companies to enhance medical treatments, the platform addresses the need for more effective interventions in aging-related health issues.
Funding: $48.0M
Rough estimate of the amount of funding raised
Funding: $48.0M
Rough estimate of the amount of funding raised
The startup offers a healthcare management platform that provides real-time health tracking, digital medical records, and preventive health programs for employees. This platform enables organizations to enhance employee well-being and productivity while managing health-related risks effectively.
Funding: $3.0M
Rough estimate of the amount of funding raised
Funding: $3.0M
Rough estimate of the amount of funding raised
Vitazi provides Oculomics-as-a-Service by using AI analytics on retinal scans to detect systemic health risks like diabetes and cardiovascular disease. The platform integrates seamlessly into existing clinical workflows, offering multi-disease detection beyond standard eye disease screening. This enables earlier intervention and supports value-based care metrics for eye care professionals.
Funding: $3.7M
Rough estimate of the amount of funding raised
Funding: $3.7M
Rough estimate of the amount of funding raised
Doc4Doc provides a 24/7 telemedicine platform connecting healthcare facilities with specialized medical consultants for rapid case review and treatment recommendations. The service enhances diagnostic accuracy and patient management by offering real-time communication and digital transmission of medical information across a broad range of specialties.
Abartys Health has developed a centralized communication platform that integrates healthcare data management for patients, providers, and insurers, enabling secure access to medical records and lab results from any device. This platform addresses the fragmentation in healthcare communication, facilitating streamlined interactions and improving data accessibility across the healthcare ecosystem.
Funding: $3.1M
Rough estimate of the amount of funding raised
Funding: $3.1M
Rough estimate of the amount of funding raised
This startup develops a health technology platform that integrates electronic medical records, analytics, electronic prescriptions, and point-of-sale systems to streamline operations within the healthcare industry. By consolidating data and communication among doctors, health providers, and patients, the platform enhances efficiency and improves patient care management.
Funding: $500.0K
Rough estimate of the amount of funding raised
Funding: $500.0K
Rough estimate of the amount of funding raised
This biotechnology company develops and manufactures clinical-grade Active Pharmaceutical Ingredients (APIs) of psilocybin, DMT, and 5-MeO-DMT for research and commercial applications. They utilize cutting-edge biosynthetic processes to create scalable, cost-effective, and environmentally friendly psychedelic compounds. EYWA partners with pharmaceutical companies and research institutions to supply high-purity materials supporting next-generation mental health treatments.
Funding: $100.0K
Rough estimate of the amount of funding raised
Funding: $100.0K
Rough estimate of the amount of funding raised